A. .V Bedina
A. .V Bedina has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Evgeniya Yu. Pashkova
Botkin Hospital; Moscow, Russian Federation; Russian Medical Academy of Postgraduate Education; Moscow, Russian Federation
3 shared publications - A. V. Gugnin
Moscow Botkin Multidisciplinary Scientific-Clinical Center, Moscow, Russia
2 shared publications - Aleksander Sergeevich Ametov
Russian Medical Academy of Continuing Professional Education
2 shared publications - Alexander V. Klimashevich
Botkin Hospital
2 shared publications - Maksim Yu. Yudin
Moscow Botkin Multidisciplinary Scientific-Clinical Center, Moscow, Russia
2 shared publications - Zurab Antonovich Bagateliya
Botkin Hospital
2 shared publications
Latest Publications
- 5 September 2026
- Published by Publishing House OKI in Antibiot Khimioter = Antibiotics and Chemotherapy
- Vol. 71 (5-6) , 45-49
Thyroidectomy as a Treatment for Complicated Thyrotoxicosis
Background . The only conservative treatment for diffuse toxic goiter currently is the use of antithyroid drugs — thiamazole and propylthiouracil. Agranulocytosis occurs in approximately 0.2–0.5% of patients, usually at the beginning of treatment with thiamazole or propylthiouracil, but may also occur later, even during repeated therapy. Mortality among patients with agranulocytosis reaches 4%. The aim of this article is to present a clinical case of a patient with a long-standing diffuse toxic goiter, as well as several relapses of thyrotoxicosis due to irregular administration of antithyroid therapy, and the development of agranulocytosis during the next course of treatment. Description of the clinical case. A detailed conservative treatment of both thyrotoxicosis and agranulocytosis is reflected. Aspects of surgical treatment and anesthetic care are discussed. Discussion . To rapidly achieve euthyroidism, both unfairly neglected methods, such as short-term inorganic iodine supplementation and modern plasmapheresis, were used. This combination of therapeutic approaches allowed for radical surgery. Conclusions . The combination of modern extracorporeal detoxification methods and inorganic iodine therapy enabled rapid achievement of euthyroidism and radical surgery in this clinical case.
- 5 September 2026
- Published by Publishing House OKI in Antibiot Khimioter = Antibiotics and Chemotherapy
- Vol. 71 (5-6) , 45-49
Thyroidectomy as a Treatment for Complicated Thyrotoxicosis
Background . The only conservative treatment for diffuse toxic goiter currently is the use of antithyroid drugs — thiamazole and propylthiouracil. Agranulocytosis occurs in approximately 0.2–0.5% of patients, usually at the beginning of treatment with thiamazole or propylthiouracil, but may also occur later, even during repeated therapy. Mortality among patients with agranulocytosis reaches 4%. The aim of this article is to present a clinical case of a patient with a long-standing diffuse toxic goiter, as well as several relapses of thyrotoxicosis due to irregular administration of antithyroid therapy, and the development of agranulocytosis during the next course of treatment. Description of the clinical case. A detailed conservative treatment of both thyrotoxicosis and agranulocytosis is reflected. Aspects of surgical treatment and anesthetic care are discussed. Discussion . To rapidly achieve euthyroidism, both unfairly neglected methods, such as short-term inorganic iodine supplementation and modern plasmapheresis, were used. This combination of therapeutic approaches allowed for radical surgery. Conclusions . The combination of modern extracorporeal detoxification methods and inorganic iodine therapy enabled rapid achievement of euthyroidism and radical surgery in this clinical case.
- Open Access
- 1 January 2025
- Published by NP Rusmedical Group in Doctor.Ru
Ovarian Struma in a Patient with Recurrent Thyrotoxicosis
Aim. To present a clinical case of struma ovarii in a patient with recurrent thyrotoxicosis. Key points. In most cases, struma ovarii is an incidental finding during histological examination following adnexectomy for a detected ovarian mass. Currently, preoperative diagnosis of struma ovarii poses significant challenges, as both clinical-laboratory manifestations and ultrasonographic features are often nonspecific. Moreover, the exceptionally rare occurrence of thyroid hormone hyperproduction by struma ovarii has led to its exclusion from the diagnostic workup of thyrotoxicosis. This report describes a case of struma ovarii detected in a patient with a previously diagnosed diffuse toxic goiter and recurrent thyrotoxicosis, who presented with an ovarian mass. Conclusion. Struma ovarii is a rare form of ovarian teratoma composed predominantly of thyroid tissue and is typically benign. Due to its extreme rarity and the absence of specific clinical, radiographic, or serum markers for this teratoma, preoperative suspicion of struma ovarii prior to surgical intervention and histological examination remains exceptionally challenging. Consequently, this condition demands further in-depth research to develop reliable methods for preoperative verification, which would optimize surgical management and minimize intervention extent. Keywords: struma ovarii, ovarian teratoma, Graves’ disease, thyrotoxicosis
- 1 January 2025
- Published by NP Rusmedical Group in Doctor.Ru
Open AccessOvarian Struma in a Patient with Recurrent Thyrotoxicosis
Aim. To present a clinical case of struma ovarii in a patient with recurrent thyrotoxicosis. Key points. In most cases, struma ovarii is an incidental finding during histological examination following adnexectomy for a detected ovarian mass. Currently, preoperative diagnosis of struma ovarii poses significant challenges, as both clinical-laboratory manifestations and ultrasonographic features are often nonspecific. Moreover, the exceptionally rare occurrence of thyroid hormone hyperproduction by struma ovarii has led to its exclusion from the diagnostic workup of thyrotoxicosis. This report describes a case of struma ovarii detected in a patient with a previously diagnosed diffuse toxic goiter and recurrent thyrotoxicosis, who presented with an ovarian mass. Conclusion. Struma ovarii is a rare form of ovarian teratoma composed predominantly of thyroid tissue and is typically benign. Due to its extreme rarity and the absence of specific clinical, radiographic, or serum markers for this teratoma, preoperative suspicion of struma ovarii prior to surgical intervention and histological examination remains exceptionally challenging. Consequently, this condition demands further in-depth research to develop reliable methods for preoperative verification, which would optimize surgical management and minimize intervention extent. Keywords: struma ovarii, ovarian teratoma, Graves’ disease, thyrotoxicosis
- Open Access
- 1 January 2024
- Published by Geotar-Media Publishing Group in Endocrinology: News, Opinions, Training
- Vol. 13 (1)
Evolution of the classification of thyroid tumors
Эволюция классификации опухолей щитовидной железы
- 1 January 2024
- Published by Geotar-Media Publishing Group in Endocrinology: News, Opinions, Training
- Vol. 13 (1)
Open AccessEvolution of the classification of thyroid tumors
Эволюция классификации опухолей щитовидной железы